Limiting the influence of pharmaceutical industry gifts on physicians: Self-regulation or government intervention?

Journal of General Internal Medicine

Volumn 25, Issue 1, 2010, Pages 79-83

  Grande, David ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Conflicts of interest; Medical professionalism; Pharmaceutical marketing

Indexed keywords

COMMERCIAL PHENOMENA; CONFLICT OF INTEREST; DRUG INDUSTRY; DRUG MARKETING; GOVERNMENT REGULATION; LICENSING; MEDICAL PRACTICE; PHYSICIAN; POLICY; PRESCRIPTION; PROFESSIONAL STANDARD; PROSPECTIVE PAYMENT; REVIEW; REWARD; SELF DISCLOSURE; UNITED STATES;

ATTITUDE OF HEALTH PERSONNEL; DRUG INDUSTRY; ETHICS, MEDICAL; GIFT GIVING; GOVERNMENT REGULATION; HUMANS; INTERPROFESSIONAL RELATIONS; PHYSICIANS; SOCIAL CONTROL, INFORMAL;

EID: 77951096894     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-009-1016-7     Document Type: Review

References (52)

1. Pharmaceutical Research and Manufacturers of America. PhRMA code on interactions with healthcare professionals. Washington, DC; 2008.
2. Harris G. Drug industry to announce revised code on marketing. New York Times 2008 July 10.
3. A Wazana 2000 Physicians and the pharmaceutical industry - Is a gift ever just a gift? JAMA 283 373 380 10.1001/jama.283.3.373 1:STN:280: DC%2BD3c7ht1ehtQ%3D%3D 10647801
4. Is your doctor tied to drug makers? New York Times 2007 Jul 2.
5. Harris G. Senators seek public listing of payments to doctors. New York Times 2007 Sep 7.
6. Waxman HA. Memorandum: The marketing of Vioxx to physicians. Washington, DC: United States House of Representatives - Committee on Government Reform; 2005.
7. HA Waxman 2005 The lessons of Vioxx: drug safety and sales N Engl J Med 352 2576 2578 10.1056/NEJMp058136 1:CAS:528:DC%2BD2MXls1WqtL8%3D 15972862
8. Meier B, Saul S. Marketing of Vioxx: how Merck played game of catch-up. New York Times 2005 February 11.
9. M Gagnon J Lexchin 2008 The cost of pushing pills: A new estimate of pharmaceutical promotion expenditures in the United States PLoS Medicine 5 29 33 10.1371/journal.pmed.0050001
10. J Greene 2007 Pharmaceutical marketing research and the prescribing physician Ann Intern Med 146 742 748 17502635
11. Opinion of the Council on Ethical and Judicial Affairs E-8.061: gifts to physicians from industry. American Medical Association. (Accessed April 30, 2009, at http://www.ama-assn.org/ama1/pub/upload/mm/Code-of-Med-Eth/opinion/ opinion8061.html )
12. PhRMA code on interactions with healthcare professionals. 2002. (Accessed April 30, 2009, at http://www.phrma.org/files/PhRMA%20Code.pdf )
13. Opinion E-8.061 Gifts to Physicians from Industry: clarifying addendum. American Medical Association. (Accessed April 30, 2008, at http://www.ama-assn. org/ama1/pub/upload/mm/Code-of-Med-Eth/opinion/opinion8061.html )
14. TA Brennan DJ Rothman L Blank, et al. 2006 Health industry practices that create conflicts of interest: A policy proposal for academic medical centers JAMA 295 429 433 10.1001/jama.295.4.429 1:CAS:528:DC%2BD28Xns1SrtQ%3D%3D 16434633
15. Association of American Medical Colleges. Industry funding of medical education - report of an AAMC task force. Washington, DC; 2008.
16. AMSA PharmFree Scorecard. American Medical Student Association, 2008. (Accessed April 30, 2009, at http://amsascorecard.org/.)
17. E Campbell R Gruen J Mountford L Miller P Clearly D Blumenthal 2007 A national survey of physician-industry relationships N Engl J Med 356 1742 1750 10.1056/NEJMsa064508 1:CAS:528:DC%2BD2sXkslCrurw%3D 17460228
18. R Gibbons F Landry D Blouch, et al. 1998 A comparison of physicians' and patients' attitudes toward pharmaceutical industry gifts J Gen Intern Med 13 151 154 10.1046/j.1525-1497.1998.00048.x 1:STN:280:DyaK1c3gtVCnsQ%3D%3D 9541370
19. JS Ross JE Lackner P Lurie CP Gross S Wolfe HM Krumholz 2007 Pharmaceutical company payments to physicians: early experiences with disclosure laws in Vermont and Minnesota JAMA 297 1216 1223 10.1001/jama.297.11.1216 1:CAS:528:DC%2BD2sXlvVWlsbw%3D 17374816
20. J Dana G Loewenstein 2003 A social science perspective on gifts to physicians from industry JAMA 290 252 255 10.1001/jama.290.2.252 12851281
21. Department of Health and Human Services - Office of the Inspector General 2003 OIG compliance program guidance for pharmaceutical manufacturers Fed Regist 68 23731 23743
22. S Chimonas DJ Rothman 2005 New federal guidelines for physician-pharmaceutical industry relations: The politics of policy formation Health Aff 24 949 960 10.1377/hlthaff.24.4.949
23. D Studdert M Mello TA Brennan 2004 Financial conflicts of interest in physicians' relationships with the pharmaceutical industry - Self-regulation in the shadow of federal prosecution N Engl J Med 351 1891 1900 10.1056/NEJMlim042229 1:CAS:528:DC%2BD2cXptFCnsrY%3D 15509824
24. § 151.47. In: Minnesota Statutes; 2006.
25. § 4632. In: Vermont Statutes; 2007.
26. An Act to Promote Cost Containment, Transparency, and Efficiency in the Delivery of Quality Health Care. General Laws of Massachusetts; 2008.
27. Payments to physicians fact sheet. The Prescription Project. (Accessed April 10, 2009, at http://prescriptionproject.org/tools/solutions-factsheets/ files/0006.pdf )
28. Physician Payments Sunshine Act of 2007 - S. 2029. Library of Congress. (Accessed April 30, 2009, at http://thomas.loc.gov/ )
29. PhRMA Statement on Senate Sunshine Act. 2008. (April 30, 2008, at http://www.phrma.org/news-room/press-releases/phrma-statement-on-the-senate- sunshine-act/ )
30. O'Reilly K. "Sunshine" bill sets $100 trigger for disclosing drug industry pay to doctors. AMNews 2009 Feb 23.
31. O'Reilly K. Drugmakers vow to disclose their payments to physicians. AMNews 2008 Nov 17.
32. D Cain G Loewenstein D Moore 2005 The dirt on coming clean: perverse effects of disclosing conflicts of interest J Legal Stud 34 1 25 10.1086/426699
33. Harris G. Doctors' ties to drug makers are put on close view. New York Times 2007 March 21.
34. Harris G. 3 Researchers at Harvard are Named in Subpoena. New York Times 2009 March 27.
35. Harris G. Psychiatrists Top List in Drug Maker Gifts. New York Times 2007 June 22.
36. § 151.461. In: Minnesota Statutes; 2006.
37. CMR 970.000: Pharmaceutical and Medical Device Manufacturer Conduct. 2009. (Accessed April 30, 2009, at http://www.mass.gov/Eeohhs2/docs/dph/regs/ 105cmr970.pdf )
38. Harris G. Minnesota limits on gifts to doctors may catch on. New York Times 2007 October 12.
39. Aitken M, Berndt ER, Cutler DM. Prescription drug spending trends in the United States: Looking beyond the turning point. Health Aff 2009;28:w151-60.
40. Prescription Information Law. In: NH Rev Stat Ann; 2006.
41. DataMonitor. Personalized physician marketing: Using physician profiling to maximize returns. New York, NY; 2001.
42. IMS Health Inc. and Verispan, LLC v. Kelly A. Ayotte, New Hampshire Attorney General. 2008. (Accessed April 30, 2009, at http://www.ca1.uscourts. gov/pdf.opinions/07-1945P-01A.pdf )
43. Prescription Data Restriction Program. American Medical Association. (Accessed April 30, 2009, at http://www.ama-assn.org/ama/no-index/about-ama/ 12054.shtml )
44. D Grande DA Asch 2009 Commercial versus social goals of tracking what doctors do N Engl J Med 360 747 749 10.1056/NEJMp0810410 1:CAS:528: DC%2BD1MXitFWrtrc%3D 19228616
45. DC ST § 3-1202.08, 3-1207.42, 3-1207.41. In: District of Columbia Code; 2008 (June 4).
46. Independent Drug Information Service. (Accessed April 30, 2009, at http://www.rxfacts.org/.)
47. Under the Influence: Can We Provide Doctors An Alternative To Biased Drug Reviews? United State Senate Special Committee on Aging, 2008. (Accessed April 30, 2009, at http://aging.senate.gov/hearing-detail.cfm?id=301126&.)
48. O'Brien M, Rogers S, Jamtvedt G, et al. Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2007;4:Art. No.: CD000409.
49. Katz P. These drug reps come bearing facts, not freebies. ACP Observer 2007 July-August.
50. W Chiong 2003 Industry-to-physician marketing and the cost of prescription drugs Am J Bioeth 3 W28 W29 14594480
51. Statehealthfacts.org: Pennsylvania providers and service use. 2007. (Accessed April 30, 2008, at http://statehealthfacts.org/profileind.jsp?cat= 8&sub=100&rgn=40 )
52. DJ Rothman WJ McDonald CD Berkowitz, et al. 2009 Professional medical associations and their relationships with industry: A proposal for controlling conflict of interest JAMA 301 1367 1372 10.1001/jama.2009.407 1:CAS:528:DC%2BD1MXktFWisL8%3D 19336712